A case series of hospitalized patients with elevated digoxin levels (Q42539916)

2 November 2017

A case series of hospitalized patients with elevated digoxin levels (English)

1 reference

2 November 2017

0 references

1 reference

Marik PE

1

1 reference

PubMed ID

9727817

2 November 2017

Fromm L

series ordinal

2

1 reference

PubMed ID

9727817

2 November 2017

language of work or name

English

0 references

publication date

1 August 1998

1 reference

American Journal of Medicine

2 November 2017

1 reference

2 November 2017

105

1 reference

2 November 2017

2

1 reference

2 November 2017

110-115

1 reference

An account of the foxglove, and some of its medical uses:with practical remarks on dropsy, and other diseases

2 November 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900195-8

End of the oldest controversy in medicine. Are we ready to conclude the debate on digitalis?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900195-8

A comparison of oral milrinone, digoxin, and their combination in the treatment of patients with chronic heart failure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900195-8

Withdrawal of digoxin from patients with chronic heart failure treated with angiotensin-converting-enzyme inhibitors. RADIANCE Study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900195-8

Randomized study assessing the effect of digoxin withdrawal in patients with mild to moderate chronic congestive heart failure: results of the PROVED trial. PROVED Investigative Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900195-8

The effect of digoxin on mortality and morbidity in patients with heart failure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900195-8

Digoxin and increased mortality among patients recovering from acute myocardial infarction: importance of digoxin dose. The SPRINT Study Group.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900195-8

Effect of digitalis treatment on survival after acute myocardial infarction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900195-8

Digitalis Investigation Group (DIG) trial: a stimulus for further research

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900195-8

A nomogram for digoxin therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900195-8

The management of chronic heart failure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900195-8

Letter: Creatinine clearance: bedside estimate.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900195-8

Digoxin toxicity in patients with high serum digoxin concentrations

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900195-8

Recognition and management of digitalis toxicity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900195-8

Plasma digoxin concentrations and digoxin toxicity in hospital patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900195-8

A Prospective Survey of the Incidence of Cardiac Intoxication with Digitalis in Patients being Admitted to Hospital and Correlation with Serum Digoxin Levels

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900195-8

Digitalis intoxication. A prospective clinical study with serum level correlations

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900195-8

The evolving pattern of digoxin intoxication: observations at a large urban hospital from 1980 to 1988.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900195-8

A concurrent audit of high digoxin plasma levels

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900195-8

Clinical use of serum digoxin concentrations

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900195-8

Digoxin pharmacokinetics in patients with high serum digoxin concentrations

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900195-8

P-glycoprotein-mediated renal tubular secretion of digoxin: the toxicological significance of the urine-blood barrier model

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900195-8

Altered distribution of digoxin in renal failure--a cause of digoxin toxicity?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900195-8

Comparison of two different loading doses of digoxin in severe renal impairment

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900195-8

Digoxin pharmacokinetics: Role of renal failure in dosage regimen design

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900195-8

An Improved Method of Digoxin Therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900195-8

Hospitalizations with adverse events caused by digitalis therapy among elderly Medicare beneficiaries

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900195-8

The effect of quinidine and other oral antiarrhythmic drugs on serum digoxin. A prospective study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900195-8

The digoxin-amiodarone interaction.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900195-8

Itraconazole decreases renal clearance of digoxin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900195-8

Digoxin toxicity secondary to clarithromycin therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900195-8

Clarithromycin-associated digoxin toxicity in the elderly

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900195-8

Digoxin-inactivating bacteria: identification in human gut flora

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900195-8

The Serum Digitalis Concentration — Does It Diagnose Digitalis Toxicity?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900195-8

Changing physician behavior in ordering digoxin assays

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900195-8

The neurohormonal hypothesis: a theory to explain the mechanism of disease progression in heart failure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900195-8

Effects of increasing maintenance dose of digoxin on left ventricular function and neurohormones in patients with chronic heart failure treated with diuretics and angiotensin-converting enzyme inhibitors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900195-8

Does digoxin provide additional hemodynamic and autonomic benefit at higher doses in patients with mild to moderate heart failure and normal sinus rhythm?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900195-8

Digoxin reduces cardiac sympathetic activity in severe congestive heart failure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900195-8

Digoxin. A neurohormonal modulator in heart failure?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900195-8

Value of digoxin in heart failure and sinus rhythm: new features of an old drug?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900195-8

Redefining the role of digoxin in the treatment of atrial fibrillation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900195-8

Management of atrial fibrillation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900195-8

Intravenous digoxin in acute atrial fibrillation. Results of a randomized, placebo-controlled multicentre trial in 239 patients. The Digitalis in Acute Atrial Fibrillation (DAAF) Trial Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900195-8

Conversion of atrial fibrillation to sinus rhythm and rate control by digoxin in comparison to placebo.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900195-8

Emergency management of atrial fibrillation and flutter: intravenous diltiazem versus intravenous digoxin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900195-8

10.1016/S0002-9343(98)00195-8

7 January 2021

Identifiers

DOI

1 reference

2 November 2017

1 reference

PubMed ID

9727817